April 13, 2026

McDermott Will & Schulte advises Surgery Partners in its acquisition of Preferred Vascular Group

April 13, 2026

What liability theories underpin the latest group health plan litigation?

McDermott Will & Schulte partners recognized to India Business Law Journal’s International A-List

April 10, 2026

McDermott Will & Schulte named D.C. Bar’s 2026 Pro Bono Law Firm of the Year

April 10, 2026

Navigating the patent cliff

April 9, 2026

McDermott Will & Schulte advises Quad-C in its investment in Dane Street

April 8, 2026

McDermott Will & Schulte Lawyers Recognized in Variety’s 2026 Legal Impact Report

April 8, 2026

McDermott advises Rubicon Partners on its acquisition of Erodex Graphite Systems

April 7, 2026

McDermott Will & Schulte advises AI6 Technologies on a fundraising led by Generali and Socadif

April 6, 2026

Michael Mestitz Recognized by National LGBTQ+ Bar Association

April 3, 2026

Seven McDermott Will & Schulte lawyers selected to serve on Law360’s 2026 Editorial Boards

April 2, 2026

Investment funds partner Kloos rejoins McDermott

April 1, 2026

McDermott Will & Schulte deepens private equity restructuring bench with arrival of Gregg Galardi

April 1, 2026

McDermott Will & Schulte expands funds platform with return of Cerberus COO of asset-backed opportunities

April 1, 2026

McDermott Will & Schulte shortlisted for Healthcare & Life Sciences Law Firm of the Year at Chambers USA Awards 2026

April 1, 2026

McDermott Will & Schulte shortlisted for four LMG Life Sciences EMEA Awards 2026

March 31, 2026

Engineering co. executives, board prevail in ESOP fight

March 31, 2026

McDermott Will & Schulte recognized in Global Arbitration Review’s GAR 100 2026